Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach
暂无分享,去创建一个
Lei Zhang | Juncai Xin | Lei Zhang | Ju Wang | Yan-Shi Hu | Ying Hu | Ju Wang | Yanshi Hu | Ying Hu | Juncai Xin
[1] F. Scheperjans. Can microbiota research change our understanding of neurodegenerative diseases? , 2016, Neurodegenerative disease management.
[2] Anumantha Kanthasamy,et al. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. , 2016, Pharmacology & therapeutics.
[3] A. Camins,et al. The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin. , 2015, Life sciences.
[4] K. Gomes,et al. Leptin in Alzheimer's disease. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[5] R. Catanzaro,et al. The gut microbiota and its correlations with the central nervous system disorders. , 2015, Panminerva medica.
[6] T. Sakurai,et al. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease , 2015, Experimental Neurology.
[7] J. Clarimón,et al. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease , 2015, Neurology.
[8] M. Mandler,et al. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease , 2015, Journal of Neuroinflammation.
[9] P. S. St George-Hyslop,et al. ATP-binding Cassette Transporter A7 (ABCA7) Loss of Function Alters Alzheimer Amyloid Processing* , 2015, The Journal of Biological Chemistry.
[10] Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer’s disease , 2015, Journal of Neuroinflammation.
[11] Seung-Chul Hong,et al. Sleep and Alzheimer’s Disease , 2015 .
[12] G. Pasinetti,et al. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization. , 2015, Molecular nutrition & food research.
[13] M. Bastin,et al. Memory binding and white matter integrity in familial Alzheimer's disease. , 2015, Brain : a journal of neurology.
[14] Joanne Wuu,et al. Resilience of Precuneus Neurotrophic Signaling Pathways Despite Amyloid Pathology in Prodromal Alzheimer’s Disease , 2015, Biological Psychiatry.
[15] I. Bezprozvanny,et al. Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease. , 2015, Seminars in cell & developmental biology.
[16] Behzad Khallaghi,et al. Impairment of Rat Spatial Learning and Memory in a New Model of Cold Water-Induced Chronic Hypothermia: Implication for Alzheimer’s Disease , 2015, Neurotoxicity Research.
[17] Margarida Silveira,et al. Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages , 2015, Comput. Biol. Medicine.
[18] M. Heneka,et al. Innate immunity in Alzheimer's disease , 2015, Nature Immunology.
[19] A. Barabasi,et al. Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.
[20] T. Hökfelt,et al. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease , 2015, Acta Neuropathologica.
[21] R. D'Hooge,et al. Rescue of impaired late–phase long-term depression in a tau transgenic mouse model , 2015, Neurobiology of Aging.
[22] Manolis Kellis,et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.
[23] C. Bethea,et al. Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques , 2015, Molecular Psychiatry.
[24] F. LaFerla,et al. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss , 2015, Hippocampus.
[25] Chieko Suzuki,et al. Changes in daily cognition and behavior of Alzheimer’s patients over time: A three-year evaluation using a daily cognition and behavior for Alzheimer’s disease scale , 2015, Dementia.
[26] M. Baumann,et al. Notch signaling and ageing. , 2015, Advances in experimental medicine and biology.
[27] M. Rantalainen,et al. An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients. , 2015, Journal of Alzheimer's disease : JAD.
[28] Li Wang,et al. Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats , 2014, Neuroscience Bulletin.
[29] D. G. Clark,et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. , 2014, JAMA neurology.
[30] Y. Li,et al. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice. , 2014, European journal of pharmacology.
[31] P. Roos. Osteoporosis in neurodegeneration. , 2014, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[32] G. Casadesus,et al. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. , 2014, Biochimica et biophysica acta.
[33] R. Tanzi,et al. Rare autosomal copy number variations in early-onset familial Alzheimer’s disease , 2014, Molecular Psychiatry.
[34] S. M. de la Monte,et al. Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.
[35] R. Mayeux,et al. Review - Part of the Special Issue: Alzheimer's Disease - Amyloid, Tau and Beyond Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers , 2014 .
[36] Yang Yang,et al. Integrating Gene Expression and Protein Interaction Data for Signaling Pathway Prediction of Alzheimer's Disease , 2014, Comput. Math. Methods Medicine.
[37] Mohammad A Kamal,et al. A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update. , 2014, CNS & neurological disorders drug targets.
[38] Joaquín Dopazo,et al. Pathway network inference from gene expression data , 2014, BMC Systems Biology.
[39] B. Hooshmand,et al. Advances in the prevention of Alzheimer's disease and dementia , 2014, Journal of internal medicine.
[40] I. Santana,et al. Obesity as a risk factor for Alzheimer’s disease: the role of adipocytokines , 2014, Metabolic Brain Disease.
[41] Jack Hunt,et al. F-box Only Protein 2 (Fbxo2) Regulates Amyloid Precursor Protein Levels and Processing* , 2014, The Journal of Biological Chemistry.
[42] B. de Strooper,et al. Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling , 2014, PloS one.
[43] Fuhai Song,et al. AlzBase: an Integrative Database for Gene Dysregulation in Alzheimer’s Disease , 2014, Molecular Neurobiology.
[44] M. Matsuoka. Protective Effects of Humanin and Calmodulin-Like Skin Protein in Alzheimer’s Disease and Broad Range of Abnormalities , 2014, Molecular Neurobiology.
[45] Paul M. Thompson,et al. Neuroimaging and genetic risk for Alzheimer’s disease and addiction-related degenerative brain disorders , 2013, Brain Imaging and Behavior.
[46] Alzheimer’s as a metabolic disease , 2013, Biogerontology.
[47] Tanya Z. Berardini,et al. The Gene Ontology (GO) Cellular Component Ontology: integration with SAO (Subcellular Anatomy Ontology) and other recent developments , 2013, J. Biomed. Semant..
[48] The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease , 2013, Acta neuropathologica communications.
[49] L. Tran,et al. Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.
[50] Cristina Marino Buslje,et al. Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid β (Aβ) Peptide Catabolism and Functionality* , 2013, The Journal of Biological Chemistry.
[51] A. Cattaneo,et al. Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation , 2013, Biochemical and biophysical research communications.
[52] J. Satoh,et al. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains , 2013, Neuropathology and applied neurobiology.
[53] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[54] O. Forlenza,et al. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease , 2012, NeuroMolecular Medicine.
[55] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[56] Margaret A. Pericak-Vance,et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression , 2012, Neurology.
[57] Marc Cruts,et al. Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.
[58] Thomas E. Nichols,et al. Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease , 2012, Neurobiology of Aging.
[59] Zhongming Zhao,et al. GenRev: exploring functional relevance of genes in molecular networks. , 2012, Genomics.
[60] Jianmin Wu,et al. PINA v2.0: mining interactome modules , 2011, Nucleic Acids Res..
[61] C. Caltagirone,et al. Impaired LTP- but not LTD-like cortical plasticity in Alzheimer's disease patients. , 2012, Journal of Alzheimer's disease : JAD.
[62] Peilin Jia,et al. A comprehensive network and pathway analysis of candidate genes in major depressive disorder , 2011, BMC Systems Biology.
[63] T. Goldberg,et al. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype , 2011, Molecular Psychiatry.
[64] M. Sabbagh,et al. Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease , 2011, Acta Neuropathologica.
[65] Anne Corbett,et al. Alzheimer's disease , 2011, The Lancet.
[66] G. Terstappen,et al. VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[68] A. Copani,et al. Alzheimer's disease: brain expression of a metabolic disorder? , 2010, Trends in Endocrinology & Metabolism.
[69] Jason H. Moore,et al. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans , 2010, Alzheimer's & Dementia.
[70] N. Ertekin-Taner. Genetics of Alzheimer disease in the pre- and post-GWAS era , 2010, Alzheimer's Research & Therapy.
[71] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[72] K. Anstey,et al. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[73] Jing Chen,et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..
[74] B. Palmer,et al. Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model. , 2009, Arthritis and rheumatism.
[75] R. Sharan,et al. Protein networks in disease. , 2008, Genome research.
[76] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[77] A. Barabasi,et al. A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.
[78] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[79] Bing Zhang,et al. WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..
[80] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[81] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[82] R. Ravi,et al. A nearly best-possible approximation algorithm for node-weighted Steiner trees , 1993, IPCO.
[83] B. Bollobás. The evolution of random graphs , 1984 .
[84] P. Erdos,et al. On the evolution of random graphs , 1984 .